» Articles » PMID: 20022691

Cross-talk Between MiRNA and Notch Signaling Pathways in Tumor Development and Progression

Overview
Journal Cancer Lett
Specialty Oncology
Date 2009 Dec 22
PMID 20022691
Citations 68
Authors
Affiliations
Soon will be listed here.
Abstract

Notch signaling pathways are known to regulate many cellular processes, including cell proliferation, apoptosis, migration, invasion, and angiogenesis, and is one of the most important signaling pathway during normal development. Recently, emerging evidences suggest that microRNAs (miRNAs) can function as key regulators of various biological and pathologic processes during tumor development and progression. Notch signaling has also been reported to be regulated through cross-talk with many pathways and factors where miRNAs appears to play a major role. This article will provide a brief overview of the published evidences for the cross-talks between Notch and miRNAs. Further, we summarize how targeting miRNAs by natural agents could become a novel and safer approach for the prevention of tumor progression and treatment.

Citing Articles

Clinical Outcomes With Notch Inhibitors in Notch-Activated Recurrent/Metastatic Adenoid Cystic Carcinoma.

Hoff C, de Sousa L, Bonini F, Lago E, Wang K, Siqueira J Cancer Med. 2025; 14(5):e70663.

PMID: 40025676 PMC: 11872804. DOI: 10.1002/cam4.70663.


Silencing of Epidermal Growth Factor-like Domain 8 Promotes Proliferation and Cancer Aggressiveness in Human Ovarian Cancer Cells by Activating ERK/MAPK Signaling Cascades.

Song Y, Kim J, Rajbongshi L, Lim Y, Ok Y, Hwang S Int J Mol Sci. 2025; 26(1.

PMID: 39796130 PMC: 11720593. DOI: 10.3390/ijms26010274.


The plasticity of epithelial cells and its potential in the induced differentiation of gastric cancer.

Yan Z, Liu Y, Yuan Y Cell Death Discov. 2024; 10(1):512.

PMID: 39719478 PMC: 11668900. DOI: 10.1038/s41420-024-02275-x.


Cancer Pathways Targeted by Berberine: Role of microRNAs.

Ali M, Mishra D, Singh R Curr Med Chem. 2024; 31(32):5178-5198.

PMID: 38303534 DOI: 10.2174/0109298673275121231228124031.


Function of microRNA‑124 in the pathogenesis of cancer (Review).

Liu Y, Yang Y, Wang X, Yin S, Liang B, Zhang Y Int J Oncol. 2023; 64(1).

PMID: 38038165 PMC: 10705041. DOI: 10.3892/ijo.2023.5594.


References
1.
Meister G, Landthaler M, Dorsett Y, Tuschl T . Sequence-specific inhibition of microRNA- and siRNA-induced RNA silencing. RNA. 2004; 10(3):544-50. PMC: 1370948. DOI: 10.1261/rna.5235104. View

2.
Kozaki K, Imoto I, Mogi S, Omura K, Inazawa J . Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer. Cancer Res. 2008; 68(7):2094-105. DOI: 10.1158/0008-5472.CAN-07-5194. View

3.
Bhaumik D, Scott G, Schokrpur S, Patil C, Campisi J, Benz C . Expression of microRNA-146 suppresses NF-kappaB activity with reduction of metastatic potential in breast cancer cells. Oncogene. 2008; 27(42):5643-7. PMC: 2811234. DOI: 10.1038/onc.2008.171. View

4.
Dufraine J, Funahashi Y, Kitajewski J . Notch signaling regulates tumor angiogenesis by diverse mechanisms. Oncogene. 2008; 27(38):5132-7. PMC: 3893692. DOI: 10.1038/onc.2008.227. View

5.
Reedijk M, Pinnaduwage D, Dickson B, Mulligan A, Zhang H, Bull S . JAG1 expression is associated with a basal phenotype and recurrence in lymph node-negative breast cancer. Breast Cancer Res Treat. 2007; 111(3):439-48. DOI: 10.1007/s10549-007-9805-3. View